CSF3 and breast carcinoma: Therefore, G-CSF was often offered after the appearance of chemotherapy-induced toxicities among Vietnamese breast cancer patients, as observed in our study (i.e., patients who received G-CSF were more likely to be those with severe hematological toxicities).